Skip to search formSkip to main contentSkip to account menu

Recurrence Risk

In genetics, the likelihood that a hereditary trait or disorder present in one family member will occur again in other family members. This is… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Risk scoring model to predict recurrence in locally advanced breast cancer (LABC) treated with neoadjuvant chemotherapy (NACT).
98 Background: Complete response (CR) to NACT portends favorable long term outcomes in LABC. There is a need for a tool to risk… 
Review
2015
Review
2015
Concordance of Van-Nuys Prognostic Index, Memorial Sloan Kettering Breast Cancer nomogram and Oncotype Dx DCIS scores in prediction of ductal carcinoma in situ (DCIS) recurrence risk.
56 Background: Ductal Carcinoma in situ (DCIS) has a wide spectrum of bioagressiveness. Three models used to assess recurrence… 
Review
2013
Review
2013
Impact of the Recurrence Score (RS) result and mismatch repair status (MMR) on agreement between oncologists (MDs) for stage II colon cancer (CC) recurrence risk (RR) assessment: A novel clinical…
349 Background: Appropriate use of prognostic and predictive markers depends on quality of evidence for clinical utility in… 
2011
2011
Concordance between the 21-gene recurrence score (RS) and the 70-gene profile (MP) in breast cancer (BC) patients (pts).
13 Background: Genomic assays are increasingly incorporated into treatment planning for pts with early stage BC to provide… 
2011
2011
Risk factors predicting recurrence in operated endometrial cancer.
e15592 Background: Early stage endometrial cancers have a good prognosis. However, these are a heterogeneous group of patients… 
2010
2010
Analysis of time-dependent patterns of treatment effect and failure to explain the predictive role of deficient mismatch repair (dMMR) in stage II and III colon cancer (CC).
3518 Background: dMMR is a favorable prognostic marker and a predictive marker for lack of benefit from 5FU-based adjuvant… 
2009
2009
Adjuvant hormone strategies in postmenopausal women with breast cancer: An economic evaluation based on the EBCTCG meta-analyses.
6574 Background: Meta-analyses conducted by the Early Breast Cancer Trialists' Collaborative Group (EBCTCG) demonstrated… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)